Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review

Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review

Bibliographic Details
Main Authors:	J Bryant, J Picot, G Levitt, I Sullivan, L Baxter, A Clegg
Format:	Article
Language:	English
Published:	NIHR Journals Library 2007-07-01
Series:	Health Technology Assessment
Online Access:	https://doi.org/10.3310/hta11270

Similar Items

Anthracycline-associated cardiotoxicity in adults: systematic review on the cardioprotective role of beta-blockers
by: Roberto Ramos Barbosa, et al.

The cardioprotective effects of probucol against Anthracycline and Trastuzumab mediated cardiotoxicity
by: Walker, Jonathan Robert
Published: (2010)

The cardioprotective effects of probucol against Anthracycline and Trastuzumab mediated cardiotoxicity
by: Walker, Jonathan Robert
Published: (2010)

Inter-Individual Variation and Cardioprotection in Anthracycline-Induced Heart Failure
by: Nadine Norton, et al.
Published: (2021-09-01)

Selenium in the Prevention of Anthracycline-Induced Cardiac Toxicity in Children with Cancer
by: Nurdan Tacyildiz, et al.
Published: (2012-01-01)

A Review on the Effect of Traditional Chinese Medicine Against Anthracycline-Induced Cardiac Toxicity
by: Xinyu Yang, et al.
Published: (2018-05-01)

Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials
by: Lesley, A. Smith, et al.
Published: (2010)

Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
by: Verrill Mark, et al.
Published: (2010-06-01)

Increasing creatine kinase activity protects against hypoxia / reoxygenation injury but not against anthracycline toxicity in vitro.
by: Sevasti Zervou, et al.
Published: (2017-01-01)

Mechanism of toxicity of anthracycline compounds : hydroxyl radical production /
by: Tobia, Abraham J., (Abraham Joseph),
Published: (1984)

Development of water-soluble prodrugs of the bisdioxopiperazine topoisomerase IIβ inhibitor ICRF-193 as potential cardioprotective agents against anthracycline cardiotoxicity
by: Hana Bavlovič Piskáčková, et al.
Published: (2021-02-01)

Cardioprotective effect of Malva verticillata against doxorubicin -induced toxicity in rats
by: Doa’a Anwar Ibrahim, et al.
Published: (2021-03-01)

Characterisation of the long-term effects of anthracycline-associated myocardial toxicity using cardiac MRI; a pilot study
by: Taylor Andrew, et al.
Published: (2009-01-01)

Cardioprotective effect of gallic acid against doxorubicin-induced myocardial toxicity in albino rats
by: J M Kulkarni, et al.
Published: (2015-01-01)

The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation.
by: J Picot, et al.
Published: (2011-12-01)

Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse.
by: Stefano Toldo, et al.
Published: (2013-01-01)

The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation
by: Picot, J., et al.
Published: (2011)

Protective Role of Enalapril in Anthracycline-Induced Cardiotoxicity: A Systematic Review
by: Yili Zhang, et al.
Published: (2020-05-01)

The effectiveness of interventions to treat severe acute malnutrition in young children: a systematic review.
by: J Picot, et al.
Published: (2012-04-01)

Diagnosis, Prevention, Treatment and Surveillance of Anthracycline-Induced Cardiovascular Toxicity in Pediatric Cancer Survivors
by: Valerie Curren, et al.
Published: (2021-01-01)

Catalytic inhibitors of topoisomerase II differently modulate the toxicity of anthracyclines in cardiac and cancer cells.
by: Anna Vavrova, et al.
Published: (2013-01-01)

Cardioprotective effect of Acorus calamus against doxorubicin-induced myocardial toxicity in albino Wistar rats
by: M Santosh Kumar, et al.
Published: (2016-01-01)

Review on the pathophysiology of anthracycline-induced cardiotoxicity
by: Tiago Alexandre de Oliveira Valente
Published: (2019)

Protects Against Anthracycline-Induced Cardiotoxicity in Early Breast Cancer Patients
by: Wei Hao MD, et al.
Published: (2020-07-01)

Mechanisms Involved in Exercise-Induced Cardioprotection: A Systematic Review
by: Juliana Pereira Borges, et al.
Published: (2015-01-01)

The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation
by: J Picot, et al.
Published: (2009-09-01)

Echocardiographic Changes after Treatment with Anthracyclines in Children
by: Hamid Amoozgar, et al.
Published: (2012-03-01)

The role of the Tei index in assessing for cardiotoxicity from anthracycline chemotherapy: a systematic review
by: Sadie Bennett, et al.
Published: (2021-05-01)

Disease-modifying drugs for multiple sclerosis: a rapid and systematic review.
by: Clegg, et al.
Published: (2000-01-01)

Evaluation of the impact of single-nucleotide polymorphisms on treatment response, survival and toxicity with cytarabine and anthracyclines in patients with acute myeloid leukaemia: a systematic review protocol
by: Taynah Cascaes Puty, et al.
Published: (2019-05-01)

Anthracycline cardiomyopathy
by: Vasiliy Nefedovich Anokhin, et al.
Published: (2011-10-01)

Anthracycline Cardiotoxicity
by: Umberto Campia, MD, MSc, et al.
Published: (2020-06-01)

Cardiotoxicity of Anthracyclines
by: Daniela Cardinale, et al.
Published: (2020-03-01)

Exploring cardioprotective potential of esculetin against isoproterenol induced myocardial toxicity in rats: in vivo and in vitro evidence
by: Chitikela P. Pullaiah, et al.
Published: (2021-07-01)

Diagnostic strategies using DNA testing for hereditary haemochromatosis in at-risk populations: a systematic review and economic evaluation
by: J Bryant, et al.
Published: (2009-04-01)

Diagnostic strategies using DNA testing for hereditary haemochromatosis in at-risk populations: a systematic review and economic evaluation
by: Bryant, J., et al.
Published: (2009)

The effectiveness of interventions to treat severe acute malnutrition in young children: a systematic review
by: Picot, Joanna, et al.
Published: (2012)

Synthesis of Anthracyclines Related to Adriamycin
by: White, Roger J.
Published: (1981)

The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation
by: Picot, J., et al.
Published: (2009)

The Transcription Profile Unveils the Cardioprotective Effect of Aspalathin against Lipid Toxicity in an In Vitro H9c2 Model
by: Rabia Johnson, et al.
Published: (2017-01-01)